Signaling pathways
-
BA8960 FGFR2-IN-1Summary: FGFR2-IN-1 is a selective inhibitor. - BA8961 MRX-2843Summary: An orally active, ATP-competitive and tyrosine kinase inhibitor (TKI).
- BA8962 PHI-101Summary: PHI-101 is an orally effective inhibitor that overcomes resistance to multiple drug-resistant mutations.
- BA8963 FLT3-IN-2Summary: FLT3-IN-2 is a FLT3 inhibitor.
- BA8964 FLT3-IN-3Summary: A potent FLT3 inhibitor.
- BA8965 4SC-203Summary: 4SC-203 is a potent multikinase inhibitor with potential antitumor activity.
- BA8966 AXL-IN-13Summary: AXL-IN-13 is a potent, orally active inhibitor.
- BA8967 OTS447Summary: An inhibitor.
- BA8968 FLT3-IN-6Summary: A potent and selective (FLT3 mutant) inhibitor.
- BA8969 FLT3-IN-4Summary: An orally effective inhibitor of Fms-like tyrosine receptor kinase 3 (=7nM).